AU3038401A - Polynucleotide arrays and their use in sequencing - Google Patents

Polynucleotide arrays and their use in sequencing Download PDF

Info

Publication number
AU3038401A
AU3038401A AU30384/01A AU3038401A AU3038401A AU 3038401 A AU3038401 A AU 3038401A AU 30384/01 A AU30384/01 A AU 30384/01A AU 3038401 A AU3038401 A AU 3038401A AU 3038401 A AU3038401 A AU 3038401A
Authority
AU
Australia
Prior art keywords
polynucleotide
molecule
ligation
array
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30384/01A
Inventor
Shankar Balasubramanian
David Bentley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Solexa Ltd Great Britain
Original Assignee
Solexa Ltd Great Britain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solexa Ltd Great Britain filed Critical Solexa Ltd Great Britain
Publication of AU3038401A publication Critical patent/AU3038401A/en
Abandoned legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00497Features relating to the solid phase supports
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00497Features relating to the solid phase supports
    • B01J2219/00527Sheets
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/0054Means for coding or tagging the apparatus or the reagents
    • B01J2219/00572Chemical means
    • B01J2219/00576Chemical means fluorophore
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00675In-situ synthesis on the substrate
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/0068Means for controlling the apparatus of the process
    • B01J2219/00702Processes involving means for analysing and characterising the products
    • B01J2219/00707Processes involving means for analysing and characterising the products separated from the reactor apparatus
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718Type of compounds synthesised
    • B01J2219/0072Organic compounds
    • B01J2219/00722Nucleotides
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718Type of compounds synthesised
    • B01J2219/0072Organic compounds
    • B01J2219/00729Peptide nucleic acids [PNA]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Biotechnology (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Composite Materials (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Description

WO 01/57248 PCT/GB01/00407 1 POLYNUCLEOTIDE ARRAYS AND THEIR USE IN SEQUENCING Field of the Invention This invention relates -o devices having an array of polynucleotides, and to the sequencing of polynucleotides. In particular, this invention discloses 5 methods for determining the sequence of arrayed polynucleotides. Background to the Invention Advances in the study of molecules have been led, in part, by improvement in technologies used to characterise the molecules or their biological reactions. In particular, the study of the nucleic acids DNA and RNA 10 has benefitted from developing technologies used for sequence analysis and the study of hybridisation events. An example of the technologies that have improved the study of nucleic acids, is the development of fabricated arrays of immobilised nucleic acids. These arrays typically consist of a high-density matrix of polynucleotides 15 immobilised onto a solid support material. Fodor et al, Trends in Biotechnology (1994) 12:19-26, describes ways of assembling the nucleic acids using a chemically sensitized glass surface protected by a mask, but exposed at defined areas to allow attachment of suitably modified nucleotide phosphoramidites. Fabricated arrays may also be manufactured by the technique of "spotting" 20 known polynucleotides onto a solid support at predetermined positions (e.g. Stimpson et al PNAS (1995) 92:6379-6383). A further development in array technology is the attachment of the polynucleotides to the solid support material to form single molecule arrays. Arrays of this type are disclosed in WO-A-00/06770. The advantage of these 25 arrays is that reactions can be monitored at the single molecule level and information on large numbers of single molecules can be collated from a single reaction. Although these arrays offer particular advantages in sequencing experiments, the preparation of arrays at the single molecule level may be more 30 difficult than at the multi-molecule level, where losses of target polynucleotide can be tolerated due to the multiplicity of the array. There is therefore a need WO 01/57248 PCT/GB01/00407 2 for improvements in the preparation of the single molecule arrays for sequencing procedures. Furthermore, for DNA arrays to be useful their sequences must be determined. US-A- 5302509 discloses a method to sequence polynucleotides 5 immobilised on a solid support. The method relies on the incorporation of fluorescently-labeled, 3'-blocked bases A, G, C and T to the immobilised polynucleotide, in the presence of DNA polymerase. The polymerase incorporates a base complementary to the target polynucleotide, but is prevented from further addition by the 3'-blocking group. The label of the incorporated base 10 can then be determined and the blocking group removed by chemical cleavage to allow further polymerisation to occur. Sequencing polynucleotides on a solid support can be difficult as the polynucleotide is typically bound to the solid support via a hybridisation reaction with a support-bound complement. Occasionally the conditions used in the 15 sequencing protocol result in disruption to the bonds formed on hybridisation and the target polynucleotide is removed from the array. Canard et al., Gene (1994) 148:1-6, discloses a DNA sequencing procedure using a relatively harsh alkali denaturation step to remove fluorescent labels from nucleotides incorporated onto a template. The alkali treatment 20 results in melting of the primer-template duplex, and Canard suggests providing a hairpin-like primer to the template to overcome this problem. The hairpin-like primer is suggested only in the context of the harsh alkali treatment with a homogeneous sample of template DNA. WO-A-98/20019 discloses compositions and methods for the preparation 25 of nucleic acid arrays. The general disclosure relates to the preparation of high density multi-molecule arrays, achieved by immobilising polynucleotides on microscopic beads attached to a solid support. Many different uses are proposed for the arrays. WO-A-97/08183 relates to nucleic acid capture molecules. Hairpin loop 30 structures are disclosed, but only in the context of capture molecules for use in hybridisation-based nucleic acid detection methods.
WO 01/57248 PCT/GB01/00407 3 WO-A-97/04131 discloses primer amplification experiments carried out with polynucleotide hairpin structures. The general teaching is of methods for amplification of the hairpin structures, and it is clear that the structures contain a polynucleotide sequence to which a separate primer sequence is hybridised. 5 The primer associates with the hairpin only through the hybridisation reaction. Summary of the Invention The present invention is based on the realisation that sample preparation and sequence analysis procedures can be improved if the target polynucleotide is maintained in spatial relationship to the primer, and the target and primer are 10 linked via a bond stronger than that of hybridisation. According to a first aspect of the invention, a device comprises an array of polynucleotide molecules immobilised on a solid support, wherein each molecule comprises a polynucleotide duplex linked via a covalent bond to form a hairpin loop structure, one end of which comprises a target polynucleotide, and 15 the array has a surface density which allows the target polynucleotides to be individually resolved. According to a further aspect of the invention, the device of the invention is used in a procedure to determine the sequence of the target polynucleotide. According to a third aspect, a method for the preparation of the device 20 comprises ligating a target polynucleotide to the 5'-end of a first molecule capable of forming a duplex as defined above, and immobilising the first molecule to the solid surface either before or after ligation. The present invention provides a method for capturing target polynucleotides from solution and immobilising them on an array to form a stable 25 primer-template complex. The target polynucleotide is maintained on the array together with the primer by bonds stronger than those formed in hybridisation, and so conditions which would otherwise result in the target or primer being dissociated from the array, may be used. This may be of particular use in genotyping experiments, where an array of genomic DNA is prepared, to allow 30 multiple sequencing reactions to be performed.
WO 01/57248 PCT/GBO1/00407 4 Description of the Invention The present invention is the formation of arrays of polynucleotides, the polynucleotides comprising a hairpin loop structure, one end of which comprises 5 a target polynucleotide, the other end comprising a relatively short polynucleotide capable of acting as a primer in the polymerase reaction. The arrays are typically high density arrays, and there are preferably at least 103 molecules/cm 2 , more preferably at least 105 molecules/cm 2 and most preferably 106-109 molecules/cm 2 . The molecules immobilised on the solid 10 support surface are also preferably at a density so that they can be considered to be single molecules, i.e. each can be individually resolved. The term "individually resolved" is used herein to specify that, when visualised, it is possible to distinguish one molecule on the array from its neighbouring molecules. Separation between individual molecules on the array will be 15 determined, in part, by the particular technique used to resolve the individual molecules. It will usually be the target polynucleotide portion that is individually resolved, as it is this which will be interrogated, e.g. by the incorporation of detectable bases. Apparatus used to image arrays are known to those skilled in the art. For 20 example, a confocal scanning microscope may be used to scan the surface of the array with a laser, to image directly a fluorophore incorporated on the individual arrayed molecule by fluorescence. Alternatively, a sensitive 2-D detector, such as a change-coupled detector, can be used to provide a 2-D image representing the individual molecules on the array. Resolving single 25 molecules on the array with a 2-D detector is possible if adjacent molecules are separated by a distance of approximately at least 250nm, preferably at least 300nm and more preferably by at least 350nm. The arrayed polynucleotide molecules each comprise a polynucleotide duplex which is used to retain a primer and a target polynucleotide in spatial 30 relationship to each other. This ensures that the primer is able to perform its priming function during a polymerase-based sequencing procedure, and is not removed during any washing step in the procedure. The target polynucleotide WO 01/57248 PCT/GBOI/00407 5 is capable of being interrogated. The term "capable of interrogation" refers to the ability of the target to act as a template during the polymerase reaction. The target polynucleotide is therefore interrogated by the incorporation of bases and the polymerase enzyme. 5 The duplex forms a hairpin loop structure, and the primer and target polynucleotides are comprised at the respective ends of the hairpin loop structure. The term "hairpin loop structure" refers to a molecular stem and loop formed from the hybridisation of complementary polynucleotides that are covalently linked at one end. The stem comprises the hybridised 10 polynucleotides and the loop is the region that links the two complementary polynucleotides. Anything from a 10 to 20 (or more) base pair double-stranded (duplex) region may be used to form the stem. In one embodiment, the structure may be formed from a single-stranded polynucleotide having complementary regions. The loop in this embodiment may be anything from 2 or more non 15 hybridised nucleotides. In a second embodiment, the structure is formed from two separate polynucleotides with complementary regions, the two polynucleotides being linked (and the loop being formed) by a linker moiety. The linker moiety forms a covalent attachment between the ends of the two polynucleotides. Linker moieties suitable for use in this embodiment will be 20 apparent to the skilled person. For example, the linker moiety may be polyethylene glycol (PEG). The term 'polynucleotide' is intended to refer to nucleic acids in general, including DNA, RNA and synthetic analogs, e.g. PNA. DNA is preferred. Preparation of the devices to form the target polynucleotide on the array 25 may be carried out by methods known to those skilled in the art. The target polynucleotide will usually be one to which a sequence determination is to be made. There are many different ways of forming the hairpin structure to incorporate the target polynucleotide. However, a preferred method is to form 30 a first molecule capable of forming a hairpin structure, and ligate the target polynucleotide to this. Ligation may be carried out either prior to or after immobilisation to the solid support. The resulting structure comprises the single- WO 01/57248 PCT/GB01/00407 6 stranded target polynucleotide at one end of the hairpin and a primer polynucleotide at the other end. In one embodiment, the target polynucleotide is genomic DNA purified using conventional methods. The genomic DNA may be PCR-amplified or used 5 directly to generate fragments of DNA using either restriction endonucleases, other suitable enzymes, a mechanical form of fragmentation or a non-enzymatic chemical fragmentation method. In the case of fragments generated by restriction endonucleases, hairpin structures bearing a complementary restriction site at the end of the first hairpin may be used, and selective ligation of one 10 strand of the DNA sample fragments may be achieved by one of two methods. Method 1 uses a first hairpin whose restriction site contains a phosphorylated 5' end. Using this method, it may be necessary to first de phosphorylate the restriction-cleaved genomic or other DNA fragments prior to 15 ligation such that only one sample strand is covalently ligated to the hairpin. Method 2: in the design of the hairpin, a single (or more) base gap can be incorporated at the 3' end (the receded strand) such that upon ligation of the DNA fragments only one strand is covalently joined to the hairpin. The base gap can be formed by hybridising a further separate polynucleotide to the 5'-end of 20 the first hairpin structure. On ligation, the DNA fragment has one strand joined to the 5'-end of the first hairpin, and the other strand joined to the 3'-end of the further polynucleotide. The further polynucleotide (and the other strand of the fragment) may then be removed by disrupting hybridisation. In either case, the net result should be covalent ligation of only one strand 25 of a DNA fragment of genomic or other DNA, to the hairpin. Such ligation reactions may be carried out in solution at optimised concentrations based on conventional ligation chemistry, for example, carried out by DNA ligases or non enzymatic chemical ligation. Should the fragmented DNA be generated by random shearing of genomic DNA or polymerase, then the ends can be filled in 30 with Klenow fragment to generate blunt-ended fragments which may be blunt end-ligated onto blunt-ended hairpins. Alternatively, the blunt-ended DNA fragments may be ligated to oligonucleotide adapters which are designed to WO 01/57248 PCT/GB01/00407 7 allow compatible ligation with the sticky-end hairpins, in the manner described previously. The hairpin-ligated DNA constructs may then be covalently attached to the surface of a solid support to generate a single molecule array (SMA), or 5 ligation may follow attachment to form the array. The arrays may then be used in procedures to determine the sequence of the target polynucleotide. In the case that the target fragments are generated via restriction digest of genomic DNA, the recognition sequence of the restriction or other nuclease enzyme will provide 4, 6, 8 bases or more of known sequence 10 (dependent on the enzyme). Further sequencing of between 10 and 20 bases on the SMA should provide sufficient overall sequence information to place that stretch of DNA into unique context with a total human genome sequence, thus enabling the sequence information to be used for genotyping and more specifically single nucleotide polymorphism (SNP) scoring. 15 Simple calculations have suggested the following based on sequencing a 10 7 molecule SMA prepared from hairpin ligation: For an 8 base pair recognition sequence, a single restriction enzyme will generate approximately 106 ends of DNA. If a stretch of 13 bases is sequenced on the SMA (i.e. 13 x 106 bases), approximately 13,000 SNPs will be detected. One application of such 20 a sample preparation and sequencing format would in general be for SNP discovery in pharmaco-genetic analysis. The approach is therefore suitable for forensic analysis or any other system which requires unambiguous identification of individuals to a level as low 103 SNPs. It is of course possible to sequence the complete target polynucleotide. 25 The sequencing method that is used to characterise the bound target may be any known in the art that measures the sequential incorporation of bases onto an extending strand. A suitable technique is disclosed in US-A-5302509 requiring the monitoring of sequential incorporation of fluorescently-labeled bases onto a complement using the polymerase reaction. Alternatives will be 30 apparent to the skilled person. Suitable reagents, including fluorescently-labeled nucleotides will be apparent to the skilled person.
WO 01/57248 PCT/GB01/00407 8 Immobilisation of the polynucleotides to the solid support may be carried out by any method known in the art, provided that covalent attachment is achieved. The solid support may be any of the conventional supports used in "DNA chips", e.g. glass slides, ceramic, silicon or plastics materials. The support 5 will typically be a flat planar surface, usually of approximately 1cm 2 . The single molecule array can be prepared by contacting a suitably prepared solid support with a dilute solution containing the polynucleotides to be arrayed. Techniques for preparing the arrays are detailed in WO-A-00/06770. Example 10 This Example illustrates the preparation of single molecule arrays by direct covalent attachment of hairpin loop structures to glass. A solution of 1% glycidoxypropyltrimethoxy-silane in 95% ethanol/5% water with 2 drops H 2
SO
4 per 500 ml was stirred for 5 minutes at room temperature. Clean, dry Spectrosil-2000 slides (TSL, UK) were placed in the 15 solution and the stirring stopped. After 1 hour the slides were removed, rinsed with ethanol, dried under N 2 and oven-cured for 30 min. at 100*C. These 'epoxide' modified slides were then treated with 1 pM of labelled DNA (5'-Cy3 CTGCTGAAGCGTCGGCAGGT-heg-aminodT-heg-ACCTGCCGACGCT-3') (SEQ ID NOS. 1 and 2) in 50 mM potassium phosphate buffer, pH 7.4 for 18 20 hours at room temperature and, prior to analysis, flushed with 50 mM potassium phosphate, 1 mM EDTA, pH 7.4. The coupling reactions were performed in sealed teflon blocks under a pre-mounted coverslip to prevent evaporation of the sample and allow direct imaging. The DNA structure was designed as a self-priming template system with 25 an internal amino group attached as an amino deoxy-thymidine held by two 18 atom hexaethylene glycol (heg) spacers, and was synthesised by conventional DNA synthesis techniques using phosphoramidite monomers. For imaging, one slide was inverted so that the chamber coverslip contacted the objective lens of an inverted microscope (Nikon TE200) via an 30 immersion oil interface. A 600 fused silica dispersion prism was coupled optically to the back of the slide through a thin film of glycerol. Laser light was directed at the prism such that at the glass/sample interface it subtends an angle WO 01/57248 PCT/GBOI/00407 9 of approximately 680 to th3 normal of the slide and subsequently undergoes Total Internal Reflection (TIR). The critical angle for glass/water interface is 660. Fluorescence from single molecules of DNA-Cy3, produced by excitation with the surface-specific evanescent wave following TIR, was collected by the 5 objective lens of the microscope and imaged onto an Intensified Charge Coupled Device (ICCD) camera (Pentamax, Princeton Instruments, NJ). The image was recorded using a 532nm excitation (frequency-doubled solid-state Nd:YAG, Antares, Coherent) with a 580nm fluorescence (580DF30, Omega Optics, USA) filter for Cy3. Images were recorded with an exposure time of 500ms at the 10 maximum gain of 10 on the ICCD. Laser powers incident at the prism were 50mW at 532nm. Single molecules were identified by single points of fluorescence with average intensities greater than 3x that of the background. Fluorescence from a single molecule was confined to a few pixels, typically a 3x3 matrix at 100x 15 magnification, and had a narrow Gaussian-like intensity profile. Single molecule fluorescence was also characterised by a one-step photobleaching process in the time course of the intensity and was used to distinguish single molecules from pixel regions containing two or more molecules, which exhibit multi-step processes. 20 To count molecules, a threshold for fluorescence intensities was first set to exclude background noise. For a control sample the background was essentially the thermal noise of the ICCD measured to be 76 counts with a standard deviation of only 6 counts. A threshold was arbitrarily chosen as a linear combination of the background, the average counts over an image and the 25 standard deviation over an image. In general, the latter two quantities provide a measure of the number of pixels and range of intensities above background. This method gave rise to threshold levels which were at least 12 standard deviations above the background with a probability of less than 1 in 144 pixels contributing from noise. By defining a single molecule fluorescent point as being 30 at least a 2x2 matrix of pixels and no larger than a 7x7, the probability of a single background pixel contributing to the counting was eliminated and clusters were ignored.
WO 01/57248 PCT/GBO1/00407 10 In this manner, the surface density of single molecules of DNA-Cy3 was measured at approximately 500 per 100 pm x 100 pm image or 5 x 106 cm 2
.

Claims (14)

1. A device comprising an array of polynucleotide molecules immobilised on a solid surface, wherein each molecule comprises a polynucleotide duplex linked via a covalent bond to form a hairpin loop structure, one end of which comprises 5 a target polynucleotide, and the array has a surface density which allows the target polynucleotides to be individually resolved.
2. A device according to claim 1, wherein immobilisation to the solid surface is via covalent attachment.
3. A device according to claims or claim 2, wherein the array has a density 10 of at least 103 molecules/cm 2 .
4. A device according to any preceding claim, wherein the array has a density of at least 106 molecules/cm 2 .
5. A device according to any preceding claim, wherein the spacing between adjacent target polynucleotides on the array is at least 100nm. 15
6. A device according to any preceding claim, wherein the polynucleotide molecules are of DNA.
7. Use of a device according to any of claims 1 to 6, in an analysis procedure to determine the sequence of the target polynucleotide.
8. Use according to claim 7, wherein the procedure is genotyping. 20
9. Use according to claim 7 or claim 8, wherein the target polynucleotides are individually resolved by optical microscopy.
10. A method for the preparation of a device according to any of claims 1 to 6, comprising ligating a target polynucleotide to the 5' end of a first molecule capable of forming a duplex as defined in claim 1, and immobilising the first 25 molecule to the solid surface either before or after ligation.
11. A method according to claim 10, wherein the immobilising is after the ligation of the target polynucleotide.
12. A method according to claim 10 or claim 11, wherein the target polynucleotide is in the form of double-stranded DNA, ligation is between one 30 strand of the DNA and the first molecule, and the other strand is removed after ligation. WO 01/57248 PCT/GBO1/00407 12
13. A method according to claim 12, wherein a further polynucleotide is hybridised to the first molecule with a one or more base gap between the further polynucleotide and the 3'-end of the first molecule, ligation is between the double-stranded DNA and the 5'-end of the first molecule and the further 5 polynucleotide and hybridisation is subsequently disrupted to remove the further polynucleotide to form the target polynucleotide.
14. A method according to any of claims 10 to 13, wherein the 5'-end of the first duplex is phosphorylated and the target polynucleotide is dephosphorylated prior to ligation. 10
AU30384/01A 2000-02-01 2001-01-31 Polynucleotide arrays and their use in sequencing Abandoned AU3038401A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0002310 2000-02-01
GBGB0002310.1A GB0002310D0 (en) 2000-02-01 2000-02-01 Polynucleotide sequencing
PCT/GB2001/000407 WO2001057248A2 (en) 2000-02-01 2001-01-31 Polynucleotide arrays and their use in sequencing

Publications (1)

Publication Number Publication Date
AU3038401A true AU3038401A (en) 2001-08-14

Family

ID=9884765

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30384/01A Abandoned AU3038401A (en) 2000-02-01 2001-01-31 Polynucleotide arrays and their use in sequencing

Country Status (9)

Country Link
EP (1) EP1252332A2 (en)
JP (1) JP2003521693A (en)
AU (1) AU3038401A (en)
CA (1) CA2398168A1 (en)
GB (1) GB0002310D0 (en)
HK (1) HK1047771A1 (en)
IL (1) IL150836A0 (en)
IS (1) IS6489A (en)
WO (1) WO2001057248A2 (en)

Families Citing this family (111)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7875440B2 (en) 1998-05-01 2011-01-25 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US6780591B2 (en) 1998-05-01 2004-08-24 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US7056661B2 (en) 1999-05-19 2006-06-06 Cornell Research Foundation, Inc. Method for sequencing nucleic acid molecules
US6818395B1 (en) 1999-06-28 2004-11-16 California Institute Of Technology Methods and apparatus for analyzing polynucleotide sequences
US9708358B2 (en) 2000-10-06 2017-07-18 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding DNA and RNA
EP1790736A3 (en) 2000-10-06 2007-08-15 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding DNA and RNA
EP1354064A2 (en) 2000-12-01 2003-10-22 Visigen Biotechnologies, Inc. Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity
JP2004524525A (en) * 2001-01-30 2004-08-12 ソレックサ リミテッド Preparation of polynucleotide array
EP2465943A3 (en) 2001-03-16 2012-10-03 Kalim Mir Linear polymer display
GB0119719D0 (en) * 2001-08-13 2001-10-03 Solexa Ltd DNA sequence analysis
GB0129012D0 (en) 2001-12-04 2002-01-23 Solexa Ltd Labelled nucleotides
US7057026B2 (en) 2001-12-04 2006-06-06 Solexa Limited Labelled nucleotides
US7414116B2 (en) 2002-08-23 2008-08-19 Illumina Cambridge Limited Labelled nucleotides
US11008359B2 (en) 2002-08-23 2021-05-18 Illumina Cambridge Limited Labelled nucleotides
EP3002289B1 (en) 2002-08-23 2018-02-28 Illumina Cambridge Limited Modified nucleotides for polynucleotide sequencing
EP1556506A1 (en) * 2002-09-19 2005-07-27 The Chancellor, Masters And Scholars Of The University Of Oxford Molecular arrays and single molecule detection
GB0304371D0 (en) * 2003-02-26 2003-04-02 Solexa Ltd DNA Sequence analysis
GB0324456D0 (en) 2003-10-20 2003-11-19 Isis Innovation Parallel DNA sequencing methods
US8637650B2 (en) 2003-11-05 2014-01-28 Genovoxx Gmbh Macromolecular nucleotide compounds and methods for using the same
US7169560B2 (en) 2003-11-12 2007-01-30 Helicos Biosciences Corporation Short cycle methods for sequencing polynucleotides
WO2005080605A2 (en) 2004-02-19 2005-09-01 Helicos Biosciences Corporation Methods and kits for analyzing polynucleotide sequences
US7170050B2 (en) 2004-09-17 2007-01-30 Pacific Biosciences Of California, Inc. Apparatus and methods for optical analysis of molecules
EP1902143A1 (en) 2005-03-29 2008-03-26 Applera Corporation Nanowire-based system for analysis of nucleic acids
EP1907571B1 (en) 2005-06-15 2017-04-26 Complete Genomics Inc. Nucleic acid analysis by random mixtures of non-overlapping fragments
US9297036B2 (en) 2005-07-01 2016-03-29 Agilent Technologies, Inc Nucleic acid probes for analysis of small RNAs and other polynucleotides
GB0514935D0 (en) 2005-07-20 2005-08-24 Solexa Ltd Methods for sequencing a polynucleotide template
ATE510930T1 (en) 2005-08-02 2011-06-15 Rubicon Genomics Inc COMPOSITIONS AND METHODS FOR EDITING AND AMPLIFICATION OF DNA USING MULTIPLE ENZYMES IN A SINGLE REACTION
GB0517097D0 (en) 2005-08-19 2005-09-28 Solexa Ltd Modified nucleosides and nucleotides and uses thereof
US7666593B2 (en) 2005-08-26 2010-02-23 Helicos Biosciences Corporation Single molecule sequencing of captured nucleic acids
SI2341140T1 (en) 2005-12-01 2017-12-29 Nuevolution A/S Enzymatic encoding methods for efficient synthesis of large libraries
US7754475B2 (en) 2006-01-25 2010-07-13 Agilent Technologies, Inc. Nucleic acid probes and microarrays for analysis of polynucleotides
US20090253581A1 (en) 2006-04-04 2009-10-08 Keygene N.V. High Throughput Detection of Molecular Markers Based on AFLP and High Throughput Sequencing
DK2038425T3 (en) 2006-07-12 2010-12-06 Keygene Nv High capacity physical mapping using AFLP
US8399188B2 (en) 2006-09-28 2013-03-19 Illumina, Inc. Compositions and methods for nucleotide sequencing
GB2457402B (en) 2006-12-01 2011-10-19 Univ Columbia Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators
WO2008096146A1 (en) 2007-02-07 2008-08-14 Solexa Limited Preparation of templates for methylation analysis
EP2725107B1 (en) 2007-10-19 2018-08-29 The Trustees of Columbia University in the City of New York DNA sequencing with non-fluorescent nucleotide reversible terminators and cleavable label modified ddNTPs and nucleic acid comprising inosine with reversible terminators
WO2009051807A1 (en) 2007-10-19 2009-04-23 The Trustees Of Columbia University In The City Of New York Design and synthesis of cleavable fluorescent nucleotides as reversible terminators for dna sequencing by synthesis
BRPI0908734A2 (en) 2008-03-17 2015-07-28 Expressive Res Bv Methods for the identification of genomic DNA in a sample and for the identification of polymorphisms, and kit
EP3269824A1 (en) 2008-03-28 2018-01-17 Pacific Biosciences Of California, Inc. Compositions and methods for nucleic acid sequencing
CN102272334B (en) 2009-01-13 2014-08-20 关键基因股份有限公司 Novel genome sequencing strategies
WO2012034007A2 (en) 2010-09-10 2012-03-15 Bio-Rad Laboratories, Inc. Size selection of dna for chromatin analysis
US9777322B2 (en) 2011-07-08 2017-10-03 Keygene N.V. Sequence based genotyping based on oligonucleotide ligation assays
EP2769007B1 (en) 2011-10-19 2016-12-07 Nugen Technologies, Inc. Compositions and methods for directional nucleic acid amplification and sequencing
GB201119903D0 (en) 2011-11-17 2011-12-28 Univ Vilnius Nucleic acid production and sequence analysis
EP4372084A3 (en) 2012-01-26 2024-08-14 Tecan Genomics, Inc. Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation
WO2013191775A2 (en) 2012-06-18 2013-12-27 Nugen Technologies, Inc. Compositions and methods for negative selection of non-desired nucleic acid sequences
US20150011396A1 (en) 2012-07-09 2015-01-08 Benjamin G. Schroeder Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing
EP2964781B1 (en) 2013-03-08 2018-01-10 Roche Diagnostics GmbH Egfr mutation blood testing
CA2902992C (en) 2013-03-08 2020-08-25 Illumina Cambridge Ltd Rhodamine compounds and their use as fluorescent labels
CN108299275A (en) 2013-03-08 2018-07-20 伊鲁米纳剑桥有限公司 Polymethine compound and its purposes as fluorescent marker
EP2971130A4 (en) 2013-03-15 2016-10-05 Nugen Technologies Inc Sequential sequencing
WO2014144883A1 (en) 2013-03-15 2014-09-18 The Trustees Of Columbia University In The City Of New York Raman cluster tagged molecules for biological imaging
ES2685549T3 (en) 2013-03-15 2018-10-09 Illumina Cambridge Limited Nucleosides or modified nucleotides
GB201308259D0 (en) 2013-05-08 2013-06-12 Iles Raymond K Cancer diagnosis and monitoring
MX371428B (en) 2013-08-19 2020-01-30 Singular Bio Inc Assays for single molecule detection and use thereof.
CN105849264B (en) 2013-11-13 2019-09-27 纽亘技术公司 For identifying the composition and method that repeat sequencing reading
US9745614B2 (en) 2014-02-28 2017-08-29 Nugen Technologies, Inc. Reduced representation bisulfite sequencing with diversity adaptors
GB201408077D0 (en) 2014-05-07 2014-06-18 Illumina Cambridge Ltd Polymethine compounds and their use as fluorescent labels
WO2016022833A1 (en) 2014-08-06 2016-02-11 Nugen Technologies, Inc. Digital measurements from targeted sequencing
US11739371B2 (en) 2015-02-18 2023-08-29 Invitae Corporation Arrays for single molecule detection and use thereof
GB201508858D0 (en) 2015-05-22 2015-07-01 Illumina Cambridge Ltd Polymethine compounds with long stokes shifts and their use as fluorescent labels
CN107922929A (en) 2015-09-09 2018-04-17 凯杰有限公司 Polymerase
GB201516987D0 (en) 2015-09-25 2015-11-11 Illumina Cambridge Ltd Polymethine compounds and their use as fluorescent labels
US10465232B1 (en) 2015-10-08 2019-11-05 Trace Genomics, Inc. Methods for quantifying efficiency of nucleic acid extraction and detection
EP3411494A4 (en) 2015-11-18 2020-03-11 Kalim U. Mir HIGH-RESOLUTION SEQUENCING
US10385214B2 (en) 2016-09-30 2019-08-20 Illumina Cambridge Limited Fluorescent dyes and their uses as biomarkers
CN109476674B (en) 2016-12-22 2021-12-10 伊鲁米纳剑桥有限公司 Coumarin compound and application thereof as fluorescent marker
WO2018148723A1 (en) 2017-02-13 2018-08-16 Qiagen Waltham Inc. Polymerase enzyme from pyrococcus abyssi
WO2018148727A1 (en) 2017-02-13 2018-08-16 Qiagen Waltham Inc. Polymerase enzyme from 9°n
WO2018148724A1 (en) 2017-02-13 2018-08-16 Qiagen Waltham Inc. Polymerase enzyme from pyrococcus furiosus
EP3580351A1 (en) 2017-02-13 2019-12-18 Qiagen Sciences, LLC Polymerase enzyme from 9°n
WO2018148726A1 (en) 2017-02-13 2018-08-16 Qiagen Waltham Inc. Polymerase enzyme from phage t4
GB201711219D0 (en) 2017-07-12 2017-08-23 Illumina Cambridge Ltd Short pendant arm linkers for nucleotides in sequencing applications
GB201716931D0 (en) 2017-10-16 2017-11-29 Illumina Cambridge Ltd New fluorescent compounds and their use as biomarkers
US11099202B2 (en) 2017-10-20 2021-08-24 Tecan Genomics, Inc. Reagent delivery system
US11293061B2 (en) 2018-12-26 2022-04-05 Illumina Cambridge Limited Sequencing methods using nucleotides with 3′ AOM blocking group
CA3103636A1 (en) 2019-03-01 2020-09-10 Illumina Cambridge Limited Tertiary amine substituted coumarin compounds and their uses as fluorescent labels
WO2020178231A1 (en) 2019-03-01 2020-09-10 Illumina, Inc. Multiplexed fluorescent detection of analytes
EP3931263A1 (en) 2019-03-01 2022-01-05 Illumina Cambridge Limited Exocyclic amine substituted coumarin compounds and their uses as fluorescent labels
NL2023327B1 (en) 2019-03-01 2020-09-17 Illumina Inc Multiplexed fluorescent detection of analytes
US11421271B2 (en) 2019-03-28 2022-08-23 Illumina Cambridge Limited Methods and compositions for nucleic acid sequencing using photoswitchable labels
JP2023510454A (en) 2019-11-27 2023-03-14 イルミナ ケンブリッジ リミテッド Pigments and compositions containing cyclooctatetraene
US12059674B2 (en) 2020-02-03 2024-08-13 Tecan Genomics, Inc. Reagent storage system
JP2023531009A (en) 2020-06-22 2023-07-20 イルミナ ケンブリッジ リミテッド Nucleosides and nucleotides with 3' acetal blocking groups
US11981964B2 (en) 2020-07-28 2024-05-14 Illumina Cambridge Limited Substituted coumarin dyes and uses as fluorescent labels
US20220195196A1 (en) 2020-12-17 2022-06-23 Illumina Cambridge Limited Alkylpyridinium coumarin dyes and uses in sequencing applications
US20220195517A1 (en) 2020-12-17 2022-06-23 Illumina Cambridge Limited Long stokes shift chromenoquinoline dyes and uses in sequencing applications
US20220195516A1 (en) 2020-12-17 2022-06-23 Illumina Cambridge Limited Methods, systems and compositions for nucleic acid sequencing
US20220195518A1 (en) 2020-12-22 2022-06-23 Illumina Cambridge Limited Methods and compositions for nucleic acid sequencing
KR20240004502A (en) 2021-05-05 2024-01-11 일루미나 케임브리지 리미티드 Fluorescent dyes containing bis-boron fused heterocycles and their use in sequencing
CN117916390A (en) 2021-05-20 2024-04-19 伊鲁米纳公司 Compositions and methods for sequencing-by-synthesis
WO2023114896A1 (en) 2021-12-16 2023-06-22 Illumina Cambridge Limited Methods for metal directed cleavage of surface-bound polynucleotides
CA3223274A1 (en) 2021-12-20 2023-06-29 Illumina, Inc. Periodate compositions and methods for chemical cleavage of surface-bound polynucleotides
WO2023122499A1 (en) 2021-12-20 2023-06-29 Illumina Cambridge Limited Periodate compositions and methods for chemical cleavage of surface-bound polynucleotides
AU2023208743A1 (en) 2022-01-20 2024-01-04 Illumina, Inc. Methods of detecting methylcytosine and hydroxymethylcytosine by sequencing
WO2023186815A1 (en) 2022-03-28 2023-10-05 Illumina Cambridge Limited Labeled avidin and methods for sequencing
EP4499872A1 (en) 2022-03-29 2025-02-05 Illumina, Inc. Systems and methods of sequencing polynucleotides
WO2023186872A1 (en) 2022-03-30 2023-10-05 Illumina Cambridge Limited Methods for chemical cleavage of surface-bound polynucleotides
AU2023246851A1 (en) 2022-03-31 2024-01-18 Illumina, Inc. Compositions and methods for improving sequencing signals
CA3222797A1 (en) 2022-03-31 2023-10-05 Ramesh NEELAKANDAN Nucleosides and nucleotides with 3' vinyl blocking group
WO2023232829A1 (en) 2022-05-31 2023-12-07 Illumina, Inc Compositions and methods for nucleic acid sequencing
US20230416279A1 (en) 2022-06-28 2023-12-28 Illumina Cambridge Limited Fluorescent dyes containing fused tetracyclic bis-boron heterocycle and uses in sequencing
WO2024039516A1 (en) 2022-08-19 2024-02-22 Illumina, Inc. Third dna base pair site-specific dna detection
WO2024068889A2 (en) 2022-09-30 2024-04-04 Illumina, Inc. Compositions and methods for reducing photo damage during sequencing
US20240240217A1 (en) 2022-12-09 2024-07-18 Illumina, Inc. Nucleosides and nucleotides with 3' blocking groups and cleavable linkers
WO2024137765A1 (en) 2022-12-22 2024-06-27 Illumina, Inc. Transition-metal catalyst compositions and methods for sequencing by synthesis
WO2024137774A1 (en) 2022-12-22 2024-06-27 Illumina, Inc. Palladium catalyst compositions and methods for sequencing by synthesis
CN119095984A (en) 2022-12-27 2024-12-06 伊路米纳有限公司 Sequencing method using 3' allyl-terminated nucleotides
WO2024206407A2 (en) 2023-03-29 2024-10-03 Illumina, Inc. Naphthalimide dyes and uses in nucleic acid sequencing
US20240327909A1 (en) 2023-03-30 2024-10-03 Illumina, Inc. Compositions and methods for nucleic acid sequencing

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8910880D0 (en) * 1989-05-11 1989-06-28 Amersham Int Plc Sequencing method
US5302509A (en) * 1989-08-14 1994-04-12 Beckman Instruments, Inc. Method for sequencing polynucleotides
US5215899A (en) * 1989-11-09 1993-06-01 Miles Inc. Nucleic acid amplification employing ligatable hairpin probe and transcription
US6974666B1 (en) * 1994-10-21 2005-12-13 Appymetric, Inc. Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
AU5171696A (en) * 1995-02-27 1996-09-18 Ely Michael Rabani Device, compounds, algorithms, and methods of molecular characterization and manipulation with molecular parallelism
WO1997004131A1 (en) * 1995-07-21 1997-02-06 Forsyth Dental Infirmary For Children Single primer amplification of polynucleotide hairpins
US5770365A (en) * 1995-08-25 1998-06-23 Tm Technologies, Inc. Nucleic acid capture moieties
US6312892B1 (en) * 1996-07-19 2001-11-06 Cornell Research Foundation, Inc. High fidelity detection of nucleic acid differences by ligase detection reaction
JP4963139B2 (en) * 1996-11-06 2012-06-27 シークエノム・インコーポレーテツド Compositions and methods for immobilizing nucleic acids on solid supports
JP2001511361A (en) * 1997-07-22 2001-08-14 ラピジーン,インコーポレイテッド Amplification and other enzymatic reactions performed on nucleic acid arrays
WO1999028494A1 (en) * 1997-12-04 1999-06-10 Packard Bioscience Company Methods of using probes for analyzing polynucleotide sequence
US20020012913A1 (en) * 1998-09-15 2002-01-31 Kevin L. Gunderson Nucleic acid analysis using complete n-mer arrays
US6448010B1 (en) * 1999-10-06 2002-09-10 Amersham Pharmacia Biotech, Inc. Method for detecting mutations using arrayed primer extension

Also Published As

Publication number Publication date
HK1047771A1 (en) 2003-03-07
IL150836A0 (en) 2003-02-12
IS6489A (en) 2002-07-31
JP2003521693A (en) 2003-07-15
GB0002310D0 (en) 2000-03-22
WO2001057248A2 (en) 2001-08-09
WO2001057248A3 (en) 2002-02-14
EP1252332A2 (en) 2002-10-30
CA2398168A1 (en) 2001-08-09

Similar Documents

Publication Publication Date Title
AU3038401A (en) Polynucleotide arrays and their use in sequencing
US7232656B2 (en) Arrayed biomolecules and their use in sequencing
US20030022207A1 (en) Arrayed polynucleotides and their use in genome analysis
EP1117827B1 (en) Methods of nucleic acid amplification and sequencing
EP1105529B2 (en) Arrayed biomolecules and their use in sequencing
EP1356120A2 (en) Arrayed polynucleotides and their use in genome analysis
EP1597397B1 (en) Dna sequence analysis
JP2010213709A (en) Length determination of nucleic acid repeat sequences by discontinuous primer extension
JP2008500047A (en) Methods and devices for sequencing nucleic acids
WO2011034690A2 (en) Centroid markers for image analysis of high density clusters in complex polynucleotide sequencing
KR20180014054A (en) Orthogonal non-blocking of nucleotides
WO2003016565A2 (en) Dna sequence analysis
US7291460B2 (en) Multiplexed systems for nucleic acid sequencing
AU2023244497A1 (en) Paired-end re-synthesis using blocked p5 primers
JP2009178159A (en) Method of nucleic acid sequence detection and nucleic acid sequence detection substrate
US20100130368A1 (en) Method and system for sequencing polynucleotides
MXPA01003266A (en) Methods of nucleic acid amplification and sequencing